U.S. Metals and Mining Stock News

myFICO introduced a new Mortgage Score Simulator aimed at helping consumers understand how different credit actions could affect their mortgage readiness. Fair Isaac partnered with Plaid to build a real time cash flow based credit scoring metric using consumers' permissioned bank data. These launches expand Fair Isaac's role in consumer credit education and signal a deeper push into data driven financial technology products. For investors watching NYSE:FICO, these product moves come as the...

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...

Ouster (NasdaqGS:OUST) has completed its acquisition of StereoLabs, a company known for AI vision and 3D camera technology. The deal brings together StereoLabs' perception software and camera systems with Ouster's digital lidar sensors. Ouster plans to use the combined technology to build a unified sensing and perception platform aimed at Physical AI applications. For you as an investor, this move is about Ouster shifting from being mainly a lidar hardware supplier to offering a broader...

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...

Fulton Financial (FULT) is back on investor radars after a recent share pullback, with the stock closing at US$20.45. That is shifting sentiment toward its valuation and the bank’s underlying financial profile. See our latest analysis for Fulton Financial. The recent 5.5% one day share price decline and 8.7% 7 day share price return dip sit against a 90 day share price return of 11.2% and 1 year total shareholder return of 7.3%. This suggests that longer term momentum is still intact despite...

In recent months, BankUnited reported solid quarterly results and continued investments in digital capabilities and new markets, even as its net interest income growth trailed the broader banking industry and analysts projected a weaker efficiency ratio ahead. This tension between operational expansion and concerns about slowing profitability has led some analysts to question how durable BankUnited’s current growth ambitions may be. Next, we’ll examine how these concerns about slowing net...

Dell Technologies (NYSE:DELL) reported record financial results, supported by a $43b AI server backlog. The company set ambitious AI growth targets and announced a $10b increase to its share repurchase authorization. Dell raised its dividend by 20% and introduced the rugged, liquid cooled PowerEdge XR9700 server for edge AI workloads. The company expanded partnerships, including a deeper alliance with Unisys and an extended collaboration with McLaren Racing in Formula 1. For investors...

Coterra Energy (CTRA) has drawn fresh attention after recent share price moves, with the stock up around 6% over the past month and about 13% over the past 3 months. See our latest analysis for Coterra Energy. Viewed over a longer stretch, Coterra Energy’s recent 1 day share price return of 1.93% sits within a broader pattern that includes a 30 day share price return of 6.03%, a year to date share price return of 15.00%, and a 1 year total shareholder return of 17.32%. Together, these figures...

Tenable Holdings (NasdaqGS:TENB) has filed a shelf registration for an offering of common stock tied to its employee stock ownership plan (ESOP). The filing covers a substantial pool of shares that may be issued to employees over time under the ESOP structure. The move highlights ongoing use of equity-based compensation as part of the company’s overall rewards and ownership approach. Tenable focuses on cybersecurity solutions, with products aimed at helping organizations identify and manage...

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...

Aurinia Pharmaceuticals reported strong commercial performance in LUPKYNIS, contributing to higher net income supported by a tax benefit. The company initiated a new clinical study of aritinercept for autoimmune diseases, expanding its development pipeline. A pediatric VOCAL study was terminated, and Aurinia is now working with regulators to address pediatric requirements. Aurinia Pharmaceuticals, listed as NasdaqGM:AUPH, is drawing attention after stronger LUPKYNIS sales and a tax benefit...

If you are wondering whether Home Depot at around US$380 is still a solid entry or starting to look expensive, you are not alone. The stock last closed at US$380.72, with returns of 1.6% over 30 days, 10.1% year to date and 69.6% over 5 years, while the 1 year return is a 1.6% decline and the 3 year return is 37.7%. Recent news coverage has focused on Home Depot's role as a bellwether for US housing and renovation trends, and what that might mean for longer term demand. At the same time,...

DHT Holdings (NYSE:DHT) has secured two one year time charter agreements for its VLCC vessels with global energy companies. The company also announced the appointment of Erik Bartnes to its Board of Directors. These updates highlight operational momentum and additional industry expertise at the governance level. For investors tracking NYSE:DHT, these moves come alongside a share price of $19.49 and strong recent stock performance, with the shares up 11.7% over the past week and 36.0% over...

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...

Synchrony Financial (NYSE:SYF) renewed its collaboration with Polaris Inc., extending customized financing options for powersports customers. The company deepened integration of its CareCredit solutions with the Planet DDS and Weave platforms, embedding patient financing into dental, orthodontic, and healthcare practice systems. These partnership moves expand Synchrony's reach across healthcare and consumer financing channels. Synchrony Financial focuses on private label credit cards,...

Eli Lilly and Incyte have received a positive opinion from the European Medicines Agency for Olumiant to treat adolescents with severe alopecia areata in Europe, marking a potential expansion of its approved uses. This regulatory progress highlights how broadening Olumiant’s eligible patient population could enhance the drug’s clinical relevance within Incyte’s immunology portfolio. We’ll now explore how this positive EMA opinion for adolescent alopecia areata may influence Incyte’s...

BlackRock's Global Infrastructure Partners and EQT are in advanced talks to acquire AES in a potential large global infrastructure transaction. The discussions, if successful, would significantly broaden BlackRock's reach in energy infrastructure through its infrastructure investing platform. The development comes as BlackRock (NYSE:BLK) trades around $1,063.23 per share, with an 11.0% return over the past year. For you as an investor, the AES talks put a spotlight on how BlackRock is using...

IonQ (NYSE:IONQ) announced a $1.8 billion agreement to acquire SkyWater Technology, aiming to build a vertically integrated quantum computing platform with in-house chip manufacturing and packaging. The company also reported the large-scale deployment of Romania's National Quantum Communication Infrastructure, one of the biggest operational quantum key distribution networks in Europe. Together, the acquisition and network rollout mark a major step in IonQ's push into secure quantum computing...

Hamilton Insurance Group (HG) is back on investors’ radar after reporting fourth quarter and full year 2025 results, declaring a special dividend of $2.00 per share and attracting renewed attention from Wall Street research desks. See our latest analysis for Hamilton Insurance Group. At a share price of $31.59, Hamilton Insurance Group has seen a 30 day share price return of 13.84% and a year to date share price return of 15.84%. The 1 year total shareholder return of 61.50% points to strong...

McDonald's (MCD) has put its new Big Arch Burger at the center of its latest U.S. menu push, using the limited time launch to test how a larger, higher priced item fits with its value reset. See our latest analysis for McDonald's. The new Big Arch launch comes as momentum in McDonald’s shares has been firm, with a 30 day share price return of 8.3% and a 1 year total shareholder return of 13.2%, building on a 5 year total shareholder return of 83.2%. If this kind of menu driven story has your...

EPR Properties recently reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$182.95 million for the quarter and US$718.36 million for the year, a swing to quarterly net income of US$66.9 million, and announced a 5.1% increase in its annualized common dividend to US$3.72 per share alongside updated 2026 earnings guidance. The company also continued reshaping its business with additional experiential real estate acquisitions, new debt and equity financing...

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...

If you are wondering whether Synopsys at around US$414 a share still makes sense for your portfolio, starting with a clear view of what you are paying for is essential. The stock is currently below recent levels, with a 5.9% decline over the last 7 days, 11.0% over 30 days, a 13.8% decline year to date and a 9.5% decline over 1 year, while the 3 year and 5 year returns sit at 12.7% and 81.7% respectively. These moves have put valuation back in focus for many investors, especially given...